Abstract
ObjectiveWe explored clinical implications of the new definition of metabolic dysfunction-associated steatotic liver disease (MASLD) by assessing its prevalence and associated cardiovascular disease (CVD) risk.DesignFrom nationwide health screening data, we...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have